title: Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.
authors.forename: W-C
authors.initials: WC
authors.lastname: Huang
authors.forename: W-L
authors.initials: WL
authors.lastname: Chen
authors.forename: Y-Y
authors.initials: YY
authors.lastname: Tsai
authors.forename: C-C
authors.initials: CC
authors.lastname: Chiang
authors.forename: J-M
authors.initials: JM
authors.lastname: Lin
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000188:drug therapy*; D002908:Chronic Disease; D006801:Humans; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab